Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for applications in pharmaceutical and healthcare products. It provides integrated contrast media intermediates, saccharin and related salts, and niche pharmaceutical intermediates and APIs, as well as CDMO/CMO and development services. Blue Jet Healthcare Limited has operations in India, Norway, the United States, Sweden, Italy, Spain, and internationally. The company was incorporated in 1968 and is headquartered in Thane, India.
Stock data | 2023 | Change |
---|---|---|
Price | $6.29 | N/A |
Market Cap | $1.09B | N/A |
Shares Outstanding | 173.47M | 0.00% |
Employees | 0 | N/A |
Shareholder Equity | 6.81B | 30.67% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.68 | N/A |
P/S Ratio | 12.69 | N/A |
P/B Ratio | 0.16 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0028 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $86.01M | N/A |
Earnings | $19.10M | N/A |
EPS | 9.23 | N/A |
Earnings Yield | 1.47 | N/A |
Gross Margin | 0.5222 | N/A |
Operating Margin | 0.2693 | N/A |
Net income margin | 0.2221 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $102.90M | N/A |
Total Debt | $410.62K | N/A |
Cash on Hand | $32.17M | N/A |
Debt to Equity | 0.0032 | -27.96% |
Cash to Debt | $78.34 | 690.24% |
Current Ratio | $3.82 | 21.72% |